Lilly weight loss drug succeeds in sleep apnea trial
Zepbound sees https://seekingalpha.com/news/4090375-eli-lilly-stock-gains-zepbound-succeeds-sleep-apnea?source=wsb_podcast:lilly_weight_loss_drug_succeeds_in_sleep_apnea_trial in Phase 3 clinical trials for sleep disorder. (0:16) Walmart https://seekingalpha.com/news/4090364-walmart-partners-with-jessica-simpson-on-fashion-assortment?source=wsb_podcast:lilly_weight_loss_drug_succeeds_in_sleep_apnea_trialwith Jessica Simpson. (3:25) Cathie Wood's flagship ARRK ETF fhttps://seekingalpha.com/news/4089724-cathie-woods-arkk-etf-falls-below-its-200-day-moving-average?source=wsb_podcast:lilly_weight_loss_drug_succeeds_in_sleep_apnea_trial key technical level. (3:42) Show Notes https://seekingalpha.com/news/4090209-theres-one-group-of-housing-stocks-that-will-benefit-rising-interest-rates-wedbush-says?source=wsb_podcast:lilly_weight_loss_drug_succeeds_in_sleep_apnea_trial...
show moreShow Notes
Wedbush says these housing stocks can benefit from rising interest rates
Episode transcripts seekingalpha.com/wsb
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Information
| Author | Seeking Alpha |
| Website | seekingalpha.com |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
